Goldman Sachs’s Lifestance Health LFST Stock Holding History

Goldman Sachs’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-566,600	Closed	-$3.12M	–	6669
2025 Q3	$3.12M	Hold	566,600	–	–	﹤0.01%	4074
2025 Q2	$2.93M	Hold	566,600	–	–	﹤0.01%	3882
2025 Q1	$3.77M	Hold	566,600	–	–	﹤0.01%	3621
2024 Q4	$4.18M	Hold	566,600	–	–	﹤0.01%	3631
2024 Q3	$3.97M	Hold	566,600	–	–	﹤0.01%	3558
2024 Q2	$2.78M	Buy	566,600 +459,300	+428%	+$2.77M	﹤0.01%	3674
2024 Q1	$662K	Sell	107,300 -4,000	-4%	-$26.9K	﹤0.01%	4594
2023 Q4	$871K	Sell	111,300 -87,500	-44%	-$564K	﹤0.01%	4454
2023 Q3	$1.37M	Buy	198,800 +41,300	+26%	+$335K	﹤0.01%	4050
2023 Q2	$1.44M	Buy	157,500 +70,000	+80%	+$582K	﹤0.01%	4104
2023 Q1	$650K	Buy	+87,500	New	+$485K	﹤0.01%	4678

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Goldman Sachs's LFST Position: Q2 2026 in Review

Goldman Sachs reduced its Lifestance Health (LFST) stake by 13% in Q2 2026, selling an estimated $2.12M and leaving 1,811,778 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

Goldman Sachs first reported a position in LFST in Q2 2021 and has held it in 21 quarters since. The position peaked at $30.1M in Q4 2024. 289 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Goldman Sachs held 1,811,778 shares of Lifestance Health worth $19.4M as of Q2 2026.
Goldman Sachs sold 274,665 Lifestance Health shares in Q2 2026, an estimated $2.12M.
Lifestance Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2665 holding.
Goldman Sachs first reported a position in Lifestance Health in Q2 2021 and has held it in 21 quarters since.
Goldman Sachs's Lifestance Health position peaked at $30.1M in Q4 2024.
289 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.